Abstract
Shany Blum1, Uzi Milman2, Chen Shapira3 & Andrew P Levy1† †Author for correspondence 1Department of Anatomy and Cell Biology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, POB 9649, Haifa, Israel Tel.: +972 4829 5202; Fax: +972 4851 4103; E-mail: alevy@ tx.technion.ac.il 2Clinical Research Unit, Clalit Health Services, Haifa and Western Galilee, and the Department of Family Medicine, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel 3Clalit Health Services, Haifa and Western Galilee, and the Lady Davis Carmel Medical Center, Haifa, Israel ‘A total of five independent longitudinal studies have demonstrated that DM individuals with the Hp 2-2 genotype have a twoto five-fold increased risk of CVD as compared with DM individuals without the Hp 2-2 genotype.’
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
